Primary Venture Partners
Primary Venture Partners is a New York-based early-stage venture capital firm established in 2004. It invests globally, focusing on pre-seed to Series A rounds in B2B SaaS, fintech, healthcare, infrastructure, and supply chain sectors. The firm is known for its low-volume, high-conviction approach, providing exceptional support to founders through its dedicated Impact team, which outnumbers investors 2:1. This team works full-time on tasks such as hiring, customer acquisition, and fundraising to accelerate portfolio companies' growth. Primary's track record includes backing unicorns like Alloy, Chief, and K Health, with portfolio companies being 2x more likely to raise a Series A and 19x more likely to reach a billion-dollar-plus valuation compared to industry averages.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Infants
Helaina
Series B in 2024
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Helaina
Series A in 2021
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Helaina
Seed Round in 2020
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.